人民财讯12月2日电，江西省人民政府办公厅印发《江西省加快脑机接口技术和产业发展若干措施》， 其中提出，加强创新产品推广。支持脑机接口医疗器械纳入创新产品推荐目录。支持符合条件的脑机接 口项目申报省工业发展专项，加快脑机接口整机产品迭代应用和规模化推广。遴选脑机接口创新应用项 目，定期发布创新应用典型案例和创新成果，推动开放应用场景。积极推进"人工智能+"行动，推动人 工智能技术加速脑机接口研发。依托省科技成果转移转化中心，组织脑机接口科技成果对接活动，加快 创新成果落地。支持牵头制修订相关标准的单位或个人申报"江西省省长质量奖和专利奖"标准项目奖和 个人奖。 ...

Core Viewpoint - Wuhan East Lake High-tech Zone is accelerating the development of the brain-computer interface (BCI) industry through a series of supportive measures aimed at fostering innovation and application in this field [1][2] Group 1: Policy Measures - The document titled "Several Measures to Support the Innovation and Development of the Brain-Computer Interface Industry" outlines policies to strengthen technological product development, promote the application of technological achievements, and build an innovative ecosystem [1] - Support is provided for enterprises in the BCI field to collaborate with universities, research institutions, and medical organizations to develop major BCI products in areas such as motion control, speech synthesis, treatment of neurological diseases, and visual reconstruction [1] - The measures include the establishment of experimental service platforms and shared equipment platforms for BCI products, as well as support for the first trials and applications of BCI products [1] Group 2: Industry Development Initiatives - The "Five Ones" implementation path for advancing the BCI industry includes forming an industry alliance, building a specialized park, issuing a special policy, releasing application scenarios, and establishing an industry fund [2] - The Hubei BCI Industry Innovation Development Alliance has been established in East Lake High-tech Zone, and efforts are underway to create a BCI industry cluster area [2] - The International Brain-Computer Interface Innovation Center, a key innovation driver, is being constructed in collaboration with Tongji Hospital and Union Hospital, aiming to provide a comprehensive service system from concept validation to clinical trials and industrial transformation [2]

Core Viewpoint - The National Medical Products Administration (NMPA) has approved the implementation of the first industry standard for brain-computer interface (BCI) medical devices in China, set to take effect on January 1, 2024, positioning China as a leader in this field internationally [1][6]. Summary by Relevant Categories Definition and Scope of BCI - The new standard defines "brain-computer interface" as a medical device capable of real-time decoding neural signals from the central nervous system, facilitating bidirectional information exchange between patients and external devices to improve or replace certain physiological functions [1][3][5]. Standardization and Regulatory Support - The standard provides a unified language for product development, production inspection, registration review, and regulation, covering core terms related to BCI medical devices, including paradigm types, signal forms, and signal processing [3]. - NMPA is expediting the establishment of multiple related standards and supportive policies to foster rapid development in the BCI medical device industry, with three additional standards already in the pipeline [9][11]. Market Growth and Future Projections - The BCI market in China is projected to exceed 6 billion yuan by 2028, with an estimated compound annual growth rate (CAGR) of 17.7% from 2024 to 2028. The global market for BCI applications in healthcare is expected to reach $40 billion by 2030 and $145 billion by 2040 [12].